|
|
||||||||
1 Pulmonary Division, Dept of Internal Medicine, 2 Institute of Pathology and 3 Dept of Cardiothoracic Surgery, University Hospital, Basel, Switzerland
CORRESPONDENCE: M. Solèr, St Claraspital, CH-4016, Basel, Switzerland. Fax: 41 616858469. E-mail: markus.soler@araspital.ch
Keywords: cost effectiveness, lung cancer, post-operative follow-up
Received: April 27, 2001
Accepted October 9, 2001
Even though complete resection is regarded as the only curative treatment for nonsmall cell lung cancer (NSCLC), >50% of resected patients die from a recurrence or a second primary tumour of the lung within 5 yrs. It remains unclear, whether follow-up in these patients is cost-effective and whether it can improve the outcome due to early detection of recurrent tumour.
The benefit of regular follow-up in a consecutive series of 563 patients, who had undergone potentially curative resection for NSCLC at the University Hospital, was analysed. The follow-up consisted of clinical visits and chest radiography according to a standard protocol for up to 10 yrs. Survival rates were estimated using the Kaplan-Meier analysis method and the cost-effectiveness of the follow-up programme was assessed.
A total of 23 patients (6.4% of the group with lobectomy) underwent further operation with curative intent for a second pulmonary malignancy. The regular follow-up over a 10-yr period provided the chance for a second curative treatment to 3.8% of all patients.
The calculated costs per life-yr gained were 90,000 Swiss Francs. The cost-effectiveness of the follow-up protocol was far above those of comparable large-scale surveillance programmes. Based on these data, the intensity and duration of the follow-up was reduced.
This article has been cited by other articles:
![]() |
J. Rubins, M. Unger, and G. L. Colice Follow-up and Surveillance of the Lung Cancer Patient Following Curative Intent Therapy: ACCP Evidence-Based Clinical Practice Guideline (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 355S - 367S. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Jeremic, J. Classen, and M. Bamberg Regular follow{-}up for patients irradiated for early stage nonsmall{-}cell lung cancer too! Eur. Respir. J., January 1, 2002; 20(4): 1065 - 1066. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |